scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution

scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution

Saved in:

Bibliographic Details
Main Authors:	Fansen Ji, Weitong Bi, Jiawei Zhang, Bingjun Tang, Ying Xiao, Huan Li, Hao Liu, Boyang Wu, Fei Yu, Shizhong Yang, Gang Xu, Jiahong Dong
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	Clinical and Translational Discovery
Online Access:	https://doi.org/10.1002/ctd2.70044
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IC2Bert: masked gene expression pretraining and supervised fine tuning for robust immune checkpoint blockade (ICB) response prediction
by: Seongyong Park, et al.
Published: (2025-08-01)

Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade
by: Evan J Lipson, et al.
Published: (2025-01-01)

Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
by: Zhiyang Huang, et al.
Published: (2025-02-01)

Pan-cancer analysis of MET mutation and its association with the efficacy of immune checkpoint blockade
by: Lijin Chen, et al.
Published: (2025-07-01)

Interaction mechanism of Soil-ICB Grid
by: Islam Elkorashi, et al.
Published: (2022-06-01)

Mutation of lysine-specific demethylase 5 is associated with enhanced tumor immunity and favorable outcomes in pan-cancer immune checkpoint blockade
by: Xiaofeng Li, et al.
Published: (2024-12-01)

Design and verification of a DMA controller based on the ICB bus
by: Su Xing, et al.
Published: (2024-01-01)

Calcium ion-binding genes can predict tumor mutation burden and immune checkpoint blockade response in a pan-cancer model
by: Wan-Yu Lin, et al.
Published: (2025-07-01)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01)

Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structures
by: Richard H. Mebane, et al.
Published: (2025-07-01)

The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy
by: Huan Zhao, et al.
Published: (2018-01-01)

Corrigendum to “Pan-cancer analysis of MET mutation and its association with the efficacy of immune checkpoint blockade” [Genes & Dis 12 (2025) 101450]
by: Lijin Chen, et al.
Published: (2025-11-01)

Single‑cell RNA sequencing reveals TMEM71 as an immunomodulatory biomarker predicting immune checkpoint blockade response in breast cancer
by: Boyang Li, et al.
Published: (2025-07-01)

Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer
by: Lin Shen, et al.
Published: (2020-10-01)

Cancer therapeutic implications of microRNAs in the regulation of immune checkpoint blockade
by: Yan Zhang, et al.
Published: (2019-08-01)

Sequentially Activated Smart DNA Nanospheres for Photoimmunotherapy and Immune Checkpoint Blockade
by: Yu Chen, et al.
Published: (2025-01-01)

Immune checkpoint blockades in gynecological cancers: A review of clinical trials
by: Hongling Peng, et al.
Published: (2022-09-01)

A system review of neoadjuvant immune checkpoint blockade for breast cancer
by: Yanle Ye, et al.
Published: (2025-03-01)

Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients
by: Richard Carvajal, et al.
Published: (2020-05-01)

Development of shellfish allergy after exposure to dual immune checkpoint blockade
by: Zachary J Brown, et al.
Published: (2018-01-01)

Dissociated response and treatment outcome with immune checkpoint blockade in advanced cancer
by: Yaping Guan, et al.
Published: (2024-12-01)

Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience
by: Madeline B. Torres, et al.
Published: (2025-04-01)

Multiple mechanisms and applications of tertiary lymphoid structures and immune checkpoint blockade
by: Zelin Li, et al.
Published: (2025-03-01)

Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
by: Jingjing Duan, et al.
Published: (2018-09-01)

scCompass: An Integrated Multi‐Species scRNA‐seq Database for AI‐Ready
by: Pengfei Wang, et al.
Published: (2025-07-01)

LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB Therapy
by: Yan Y, et al.
Published: (2025-01-01)

Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite
by: Giorgia Renga, et al.
Published: (2022-03-01)

Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade
by: Keaton I Jones, et al.
Published: (2018-11-01)

Patient-specific HLA-I subtypes predict response to immune checkpoint blockade
by: Kyrillus S. Shohdy, et al.
Published: (2025-12-01)

Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice
by: Onno Kranenburg, et al.
Published: (2022-12-01)

Overcoming immunosuppression in cancer: how ketogenic diets boost immune checkpoint blockade
by: Victoria E. Stefan, et al.
Published: (2024-11-01)

CD74 is a potential biomarker predicting the response to immune checkpoint blockade
by: Wen-Qi Shi, et al.
Published: (2024-10-01)

Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade
by: Ting Zhang, et al.
Published: (2025-06-01)

Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade
by: Loulieta Nazerai, et al.
Published: (2023-12-01)

Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles
by: Yuxuan Liu, et al.
Published: (2024-11-01)

Mitochondria-targeted photothermal-chemodynamic therapy enhances checkpoint blockade immunotherapy on colon cancer
by: Benchao Zheng, et al.
Published: (2025-04-01)

Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models
by: Chrystal Paulos, et al.
Published: (2023-01-01)

Unveiling alternative splicing dynamics in activated T lymphocytes and their implications for immune checkpoint blockade efficacy
by: Elad Zisman, et al.
Published: (2025-05-01)

Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma
by: Ya Guo, et al.
Published: (2022-01-01)

Heterogeneity in polyamine metabolism dictates prognosis and immune checkpoint blockade response in hepatocellular carcinoma
by: Jianyan Pan, et al.
Published: (2025-02-01)